Clinical Trial Update: Strong Albumin Solutions in Patients With Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on Phase 2 and Phase 3 studies evaluating strong albumin solutions in patients with sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Strong Albumin Solutions (Human serum albumin)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Sepsis, Septic Shock | Phase 2, Phase 3 | Status: COMPLETED